Litvack Frank 4
4 · CAPRICOR THERAPEUTICS, INC. · Filed Jan 6, 2025
Insider Transaction Report
Form 4
Litvack Frank
Director
Transactions
- Award
Stock Option (Right to Buy)
2025-01-02+50,000→ 50,000 totalExercise: $14.96Exp: 2035-01-02→ Common Stock (50,000 underlying)
Holdings
- 46,278(indirect: By Trust)
Common Stock
- 107,382
Common Stock
Footnotes (3)
- [F1]Balance adjusted to correct a prior inadvertent miscalculation.
- [F2]Held by Litvack Curtis Family Trust for which the Reporting Person serves as trustee.
- [F3]The shares vest 1/12th of the first day of each month, commencing February 1, 2025, with the last month vesting on December 31, 2025, until the stock option becomes fully vested and exercisable. The award pertains to annual board service as Executive Chairman. The option is subject to early exercise and, therefore, all or any part of the option can be exercised at any time. If the reporting person elects to take advantage of the early exercise feature and purchase shares prior to the vesting of such shares, the shares will be deemed restricted stock and will be subject to a repurchase option in favor of the Issuer if the reporting person's service to the Issuer terminates prior to vesting.